Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 40, Issue 4, 1997, Pages 710-717

  Mustila, Anu ^a,b   Korpela, Markku ^a   Mustonen, Jukka ^c   Helin, Heikki ^a   Huhtala, Heini ^d   Soppi, Esa ^a   Pasternack, Amos ^c   Miettinen, Ari ^b  

^a PFIZER INC   (United States)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; BIOLOGICAL MARKERS; CHILD; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULONEPHRITIS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED;

EID: 0030979209     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400417     Document Type: Article

References (45)

1. Van der Woude FJ, Lobatto S, Permin H, van der Giessen M, Rasmussen N, Wiik A, van Es LA, van der Hem GK, The TH: Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet i:425-429, 1985
2. Gross WL, Lüdemann G, Kiefer G, Lehmann H: Anticytoplasmic antibodies in Wegener's granulomatosis (letter). Lancet i:806, 1986
3. Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651-1657, 1988
4. Nölle B, Specks U, Lüdemann J, Rohbach MS, DeRemee RA, Gross WL: Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 111:28-40, 1989
5. Jennette JC, Wilkman AS, Falk RJ: Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135:921-930, 1989
6. Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, The TH, von dem Borne AEGK, Kallenberg CGM: Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 37:799-806, 1990
7. Cohen Tervaert JW, Limburg PC, Elema JD, Huitema MG, Horst G, The TH, Kallenberg CGM: Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 91: 59-66, 1991
8. Cohen Tervaert JW, Huitema MG, Hené RJ, Sluiter WJ, The TH, van der Hem GK, Kallenberg CGM: Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336:709-711, 1990
9. Goldschmeding R, van der Shoot CE, ten Bokkel Huinink D, Hack CE, van den Ende ME, Kallenberg CGM, von dem Borne AEGK: Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 84:1577-1587, 1989
10. Niles JL, McCluskey RT, Ahmad MF, Arnaout MA: Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 74:1888-1893, 1989
11. Lüdemann J, Utecht B, Gross WL: Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 171:357-362, 1990
12. Jennette JC, Hoidal JH, Falk RJ: Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 78:2263-2264, 1990
13. Cohen Tervaert JW, Goldschmeding R, Elema JD, Limburg PC, van der Giessen M, Huitema MG, Koolen MI, Hené RJ, The TH, van der Hem GK, von dem Borne AEGK, Kallenberg CGM: Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 33:1264-1272, 1990
14. Snook JA, Chapman RW, Fleming K, Jewell DP: Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 76:30-33, 1989
15. Saxon A, Shanahan F, Landers C, Ganz T, Targan S: A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202-210, 1990
16. Wiik A, Jensen E, Friis J: Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. Ann Rheum Dis 33:515-522, 1974
17. Savige JA, Gallichio MC, Stockman A, Cunningham TJ, Rowley MJ, Georgiou T, Davies D: Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis. Clin Exp Immunol 86:92-98, 1991
18. Braun MG, Csernok E, Schmitt WH, Flesch BK, Gross WL: Incidence and specificity of p-ANCA in rheumatic diseases. In, ANCA-Associated Vasculitis: Immunological and Clinical Aspects. Edited by WL Gross. London, Plenum, 1993
19. Waldendorf M, Schneider M: Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. In, ANCA-Associated Vasculitis: Immunological and Clinical Aspects. Edited by WL Gross. London, Plenum, 1993
20. Hagen EC, Ballieux BEPB, van Es LA, Daha MR, van der Woude FJ: Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood 81:1996-2002, 1993
21. Gross WL, Schmitt WH, Csernok E: Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective. Am J Kidney Dis 18:175-179, 1991
22. Juby A, Johnston C, Davis P, Russell S: Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felly's syndrome. Br J Rheumatol 31:185-188, 1992
23. Lassoued S, Sixou L, Oksman F, Pages M, Fournie A: Antineutrophil cytoplasmic antibodies and antibodies to myeloperoxidase in rheumatoid arthritis (letter). Arthritis Rheum 34:1069-1070, 1991
24. Coremans IEM, Hagen EC, Daha MR, van der Woude FJ, van der Voort EAM, Kleijburg-van der Keur C, Breedweld FC: Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 35:1466-1475, 1992
25. Mulder AHL, Horst G, van Leeuwen MA, Limburg PC, Kallenberg CGM: Antineutrophil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlations. Arthritis Rheum 36:1054-1060, 1993
26. Röther E, Metzger D, Lang B, Melchers I, Peter HH: Antineutrophil cytoplasm antibodies (ANCA) in rheumatoid arthritis: relationship to HLA-DR phenotypes, rheumatoid factor, antinuclear antibodies and disease seventy. Rheumatol Int 14:155-161, 1994
27. Bosch X, Llena J, Collado A, Font J, Mirapeix E, Ingelmo M, Muños-Gómez J, Urbano-Márquez A: Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis. J Rheumatol 22:2038-2045, 1995
28. Afeltra A, Sebastiani GD, Galeazzi M, Caccavo D, Ferri GM, Marcolongo R, Bonomo L: Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis. J Rheumatol 23:10-15, 1996
29. De Bandt M, Meyer O, Haim T, Kahn M-F: Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients. Br J Rheumatol 35:38-43, 1996
30. Helin HJ, Korpela MM, Mustonen JT, Pasternack AI: Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 38:242-247, 1995
31. Korpela M: Rheumatoid arthritis and the kidneys: a cross-sectional study on the prevalence, clinical significance and risk of renal and urinary tract diseases in patients with rheumatoid arthritis. Publications of the Social Insurance Institution, Helsinki, Finland, ML: 122, 1993
32. Korpela M, Mustonen J, Heikkinen A, Helin H, Pasternack A: Isolated microscopic hematuria in patients with rheumatoid arthritis compared with age and sex matched controls: a population based study. J Rheumatol 22:427-431, 1995
33. Ropes MW, Bennett GA, Cobb S, Jacox R, Jesser RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9:175-176, 1958
34. Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 140:659-662, 1949
35. Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 23:137-145, 1980
36. Wiik A: Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 97:12-13, 1989
37. Wiik A: Granulocyte-specific antinuclear antibodies. Allergy 35: 263-289, 1980
38. Hagen EC, Ballieux BEPB, Daha MR, van Es LA, van der Woude FJ: Fundamental and clinical aspects of antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 11:199-207, 1992
39. Cambridge G, Williams M, Leaker B. Corbett M, Smith CR: Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass. Ann Rheum Dis 53:24-29, 1994
40. Ewert BH, Jennette JC, Falk RJ: The pathogenic role of antineutrophil cytoplasmic antibodies. Am J Kidney Dis 18: 188-195, 1991
41. Jennette JC, Falk RJ: Disease associations and pathogenic role of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 4:9-15, 1992
42. Gross WL, Schmitt WH, Csernok E: ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 91:1-12, 1993
43. Jennette JC, Falk RJ: The pathology of vasculitis involving the kidney. Am J Kidney Dis 24:130-141, 1994
44. Tomer Y, Gilburd B, Blank M, Lider O, Hershkoviz R, Fishman P, Zigelman R, Meroni P-L, Wiik A, Shoenfeld Y: Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice: pathogenetic role in experimental vasculitis. Arthritis Rheum 38:1375-1381, 1995
45. Brouwer E, Huitema MG, Klok PA, Cohen Tervaert JW, Weening JJ, Kallenberg CGM: Anti-myeloperoxidase associated proliferative glomerulonephritis: an animal model. J Exp Med 177:905-914, 1993